NCT02569827 - Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore | Biotech Hunter

Timeline

Start Date

December 31, 2018

Primary Completion Date

August 8, 2019

Study Completion Date

August 8, 2019

Conditions

Dengue Fever

Interventions

DRUG

Celgosivir

Celgosivir 150 mg Q6H for 5 days (total of 20 doses = 3000 mg celgosivir total).

DRUG

Modipafant 50mg

Modipafant 50 mg Q12H alternating with placebo Q12H for 5 days (total of 10 modipafant doses = 500 mg modipafant)

DRUG

Placebo

Placebo Q6H for 5 days

DRUG

Modipafant 100mg

Modipafant 100 mg Q12H alternating with placebo Q12H for 5 days (total of modipafant 10 doses = 1000 mg modipafant)

Trial Locations (1)

Singhealth Investigational Medicine Unit, Singapore